Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 557

1.

Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?

Ziolkowski SL, Long J, Baker JF, Chertow GM, Leonard MB.

J Ren Nutr. 2019 Jan 29. pii: S1051-2276(18)30283-8. doi: 10.1053/j.jrn.2018.11.011. [Epub ahead of print]

PMID:
30709713
2.

Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows.

Leypoldt JK, Prichard S, Chertow GM, Alvarez L.

Blood Purif. 2019 Jan 30:1-8. doi: 10.1159/000495022. [Epub ahead of print]

PMID:
30699416
3.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
4.

Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.

Schwantes-An TH, Liu S, Stedman M, Decker BS, Wetherill L, Edenberg HJ, Vatta M, Foroud TM, Chertow GM, Moe SM.

Am J Nephrol. 2019;49(2):125-132. doi: 10.1159/000496060. Epub 2019 Jan 22.

PMID:
30669147
5.

Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis.

Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE 3rd, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD.

Clin J Am Soc Nephrol. 2019 Jan 21. pii: CJN.06190518. doi: 10.2215/CJN.06190518. [Epub ahead of print]

PMID:
30665924
6.

Market Consolidation and Mortality in Patients Initiating Hemodialysis.

Erickson KF, Winkelmayer WC, Ho V, Bhattacharya J, Chertow GM.

Value Health. 2019 Jan;22(1):69-76. doi: 10.1016/j.jval.2018.06.008. Epub 2018 Jul 27.

PMID:
30661636
7.

Prospective Biopsy-Based Study of Chronic Kidney Disease of Unknown Etiology in Sri Lanka.

Anand S, Montez-Rath ME, Adasooriya D, Ratnatunga N, Kambham N, Wazil A, Wijetunge S, Badurdeen Z, Ratnayake C, Karunasena N, Schensul SL, Valhos P, Haider L, Bhalla V, Levin A, Wise PH, Chertow GM, Barry M, Fire AZ, Nanayakkara N.

Clin J Am Soc Nephrol. 2019 Jan 18. pii: CJN.07430618. doi: 10.2215/CJN.07430618. [Epub ahead of print]

PMID:
30659059
8.

Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis.

Lin E, Bhattacharya J, Chertow GM.

J Am Soc Nephrol. 2019 Feb;30(2):323-335. doi: 10.1681/ASN.2018080858. Epub 2019 Jan 3.

PMID:
30606782
9.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2018 Dec 19. pii: S0272-6386(18)31087-4. doi: 10.1053/j.ajkd.2018.10.006. [Epub ahead of print]

PMID:
30578152
10.

Randomized trial of intravenous iron-induced hypophosphatemia.

Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W.

JCI Insight. 2018 Dec 6;3(23). pii: 124486. doi: 10.1172/jci.insight.124486. [Epub ahead of print]

11.

Would government compensation of living kidney donors exploit the poor? An empirical analysis.

Held PJ, McCormick F, Chertow GM, Peters TG, Roberts JP.

PLoS One. 2018 Nov 28;13(11):e0205655. doi: 10.1371/journal.pone.0205655. eCollection 2018.

12.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
13.

The Terrible Toll of the Kidney Shortage.

McCormick F, Held PJ, Chertow GM.

J Am Soc Nephrol. 2018 Dec;29(12):2775-2776. doi: 10.1681/ASN.2018101030. Epub 2018 Nov 12. No abstract available.

PMID:
30420419
14.

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.

Block GA, Pergola PE, Fishbane S, Martins JG, LeWinter RD, Uhlig K, Neylan JF, Chertow GM.

Nephrol Dial Transplant. 2018 Oct 30. doi: 10.1093/ndt/gfy318. [Epub ahead of print]

PMID:
30380116
15.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC.

J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.

16.

Payer Type, Race/Ethnicity, and the Timing of Surgical Management of Urinary Stone Disease.

Brubaker WD, Dallas KB, Elliott CS, Pao AC, Chertow GM, Leppert JT, Conti SL.

J Endourol. 2019 Feb;33(2):152-158. doi: 10.1089/end.2018.0614. Epub 2018 Nov 16.

PMID:
30343603
17.

Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?

Chang TI, Reboussin DM, Chertow GM, Cheung AK, Cushman WC, Kostis WJ, Parati G, Riessen E, Shapiro B, Stergiou GS, Tsioufis K, Whelton PK, Whittle J, Wright JT, Papademetriou V.

J Clin Hypertens (Greenwich). 2018 Nov;20(11):1644-1645. doi: 10.1111/jch.13395. Epub 2018 Oct 17. No abstract available.

18.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

Chertow GM, Appel GB, Block GA, Chin MP, Coyne DW, Goldsberry A, Kalantar-Zadeh K, Meyer CJ, Molitch ME, Pergola PE, Raskin P, Silva AL, Spinowitz B, Sprague SM, Rossing P.

J Diabetes Complications. 2018 Dec;32(12):1113-1117. doi: 10.1016/j.jdiacomp.2018.09.005. Epub 2018 Sep 13.

19.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, Dwyer JP, Hamburg NM, Kitzman D, Lash J, Lustigova E, Miracle CM, Oparil S, Raj DS, Weiner DE, Taylor A, Vita JA, Yunis R, Chertow GM, Chonchol M.

PLoS One. 2018 Sep 26;13(9):e0203305. doi: 10.1371/journal.pone.0203305. eCollection 2018.

20.

Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.

Brady BM, Zhao B, Niu J, Winkelmayer WC, Milstein A, Chertow GM, Erickson KF.

JAMA Intern Med. 2018 Oct 1;178(10):1358-1367. doi: 10.1001/jamainternmed.2018.3756.

PMID:
30208398
21.

Frailty Among Patients Receiving Hemodialysis: Evolution of Components and Associations With Mortality.

Johansen KL, Delgado C, Kaysen GA, Chertow GM, Chiang J, Dalrymple LS, Segal MR, Grimes BA.

J Gerontol A Biol Sci Med Sci. 2019 Feb 15;74(3):380-386. doi: 10.1093/gerona/gly206.

PMID:
30192916
22.

Ferumoxytol for the treatment of iron deficiency anemia.

Auerbach M, Chertow GM, Rosner M.

Expert Rev Hematol. 2018 Oct;11(10):829-834. doi: 10.1080/17474086.2018.1518712. Epub 2018 Sep 14.

PMID:
30188740
23.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.

Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS; ISCHEMIA-CKD Research Group.

Am Heart J. 2018 Nov;205:42-52. doi: 10.1016/j.ahj.2018.07.023. Epub 2018 Aug 1.

24.

Use of Estimating Equations for Dosing Antimicrobials in Patients with Acute Kidney Injury Not Receiving Renal Replacement Therapy.

Awdishu L, Connor AI, Bouchard J, Macedo E, Chertow GM, Mehta RL.

J Clin Med. 2018 Aug 11;7(8). pii: E211. doi: 10.3390/jcm7080211.

25.

Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.

Chiang JM, Kaysen GA, Segal M, Chertow GM, Delgado C, Johansen KL.

Nephrol Dial Transplant. 2018 Aug 1. doi: 10.1093/ndt/gfy252. [Epub ahead of print]

PMID:
30085235
26.

Risk-benefit profile of intensive blood pressure treatment - Authors' reply.

Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Cheung AK, Whelton PK, Chertow GM.

Lancet Diabetes Endocrinol. 2018 Aug;6(8):602. doi: 10.1016/S2213-8587(18)30200-6. No abstract available.

PMID:
30053986
27.

A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".

Strauss WE, Franklin Adkinson N, Macdougall IC, Auerbach M, Kaper RF, Chertow GM, Krop JS.

Am J Hematol. 2018 Sep;93(9):E232-E233. doi: 10.1002/ajh.25200. Epub 2018 Aug 6. No abstract available.

PMID:
30016554
28.

Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.

Moe SM, Long J, Schwantes-An TL, Decker BS, Wetherill L, Edenberg HJ, Xuei X, Vatta M, Foroud TM, Chertow GM.

Nephrol Dial Transplant. 2018 Jul 2. doi: 10.1093/ndt/gfy191. [Epub ahead of print]

PMID:
29982608
29.

Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample.

Bradshaw C, Zheng Y, Silver SA, Chertow GM, Long J, Anand S.

J Gen Intern Med. 2018 Sep;33(9):1520-1527. doi: 10.1007/s11606-018-4531-6. Epub 2018 Jun 18.

PMID:
29916026
30.

Response by Beddhu et al to Letters Regarding Article, "Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control".

Beddhu S, Chertow GM, Cheung AK, Cushman WC, Greene T, Wei G, Boucher R, Whelton PK; SPRINT Research Group.

Circulation. 2018 Jun 12;137(24):2668-2669. doi: 10.1161/CIRCULATIONAHA.118.034738. No abstract available.

PMID:
29891628
31.

Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD.

Bansal N, Zelnick LR, Himmelfarb J, Chertow GM.

Am J Kidney Dis. 2018 Nov;72(5):662-672. doi: 10.1053/j.ajkd.2018.03.030. Epub 2018 Jun 6.

PMID:
29885923
32.

Mandating Staffing Ratios in Hemodialysis Facilities: California SB 349 and Unintended Consequences.

Rastogi A, Chertow GM.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1110-1112. doi: 10.2215/CJN.03030318. Epub 2018 Jun 6. No abstract available.

PMID:
29875201
33.

Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD.

Kurella Tamura M, Desai M, Kapphahn KI, Thomas IC, Asch SM, Chertow GM.

J Am Soc Nephrol. 2018 Aug;29(8):2169-2177. doi: 10.1681/ASN.2017121273. Epub 2018 May 22.

PMID:
29789430
34.

Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.

Lozano-Ortega G, Waser N, Bensink ME, Goring S, Bennett H, Block GA, Chertow GM, Trotman ML, Cooper K, Levy AR, Belozeroff V.

J Comp Eff Res. 2018 Jul;7(7):693-707. doi: 10.2217/cer-2018-0015. Epub 2018 May 15.

PMID:
29762046
35.

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, Ix JH, Chonchol M, Kramer H, Cheung AK, Kimmel PL, Whelton PK, Chertow GM.

Lancet Diabetes Endocrinol. 2018 Jul;6(7):555-563. doi: 10.1016/S2213-8587(18)30099-8. Epub 2018 Apr 21.

PMID:
29685860
36.

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.

Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA.

Nephrol Dial Transplant. 2019 Jan 1;34(1):90-99. doi: 10.1093/ndt/gfy055.

37.

Chronic kidney disease care models in low- and middle-income countries: a systematic review.

Stanifer JW, Von Isenburg M, Chertow GM, Anand S.

BMJ Glob Health. 2018 Apr 1;3(2):e000728. doi: 10.1136/bmjgh-2018-000728. eCollection 2018.

38.

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.

Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):339-346. doi: 10.1093/ndt/gfy061.

39.

Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference?

Mittakanti HR, Conti SL, Pao AC, Chertow GM, Liao JC, Leppert JT, Elliott CS.

Urology. 2018 Jul;117:44-49. doi: 10.1016/j.urology.2018.03.019. Epub 2018 Mar 27.

PMID:
29601836
40.

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

Lin E, Chertow GM, Yan B, Malcolm E, Goldhaber-Fiebert JD.

PLoS Med. 2018 Mar 27;15(3):e1002532. doi: 10.1371/journal.pmed.1002532. eCollection 2018 Mar.

41.

Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.

Pergola PE, Fishbane S, LeWinter RD, Neylan JF, Uhlig K, Block GA, Chertow GM.

Am J Hematol. 2018 Jun;93(6):E154-E156. doi: 10.1002/ajh.25088. Epub 2018 Mar 30. No abstract available.

42.

Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis.

Cheng XS, Kim WR, Tan JC, Chertow GM, Goldhaber-Fiebert J.

Transplantation. 2018 May;102(5):e219-e228. doi: 10.1097/TP.0000000000002148.

PMID:
29554056
43.

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.

Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey P.

Kidney Int. 2018 Jun;93(6):1475-1482. doi: 10.1016/j.kint.2017.12.014. Epub 2018 Mar 7.

PMID:
29525393
44.

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM.

Am J Kidney Dis. 2018 Jun;71(6):851-865. doi: 10.1053/j.ajkd.2017.12.009. Epub 2018 Feb 27.

PMID:
29496260
45.

Updated guidelines for the diagnosis and management of high blood pressure: implications for clinical practice in nephrology.

Wyatt CM, Chertow GM.

Kidney Int. 2018 Apr;93(4):768-770. doi: 10.1016/j.kint.2018.01.017. Epub 2018 Feb 21. No abstract available.

PMID:
29475561
46.

Market Competition and Health Outcomes in Hemodialysis.

Erickson KF, Zheng Y, Ho V, Winkelmayer WC, Bhattacharya J, Chertow GM.

Health Serv Res. 2018 Oct;53(5):3680-3703. doi: 10.1111/1475-6773.12835. Epub 2018 Feb 22.

PMID:
29468675
47.

Antihypertensive medication withholding practices in hemodialysis: A survey study of patients and providers.

Haase SB, Chang S, Schiller B, Chertow GM, Chang TI.

Hemodial Int. 2018 Jul;22(3):415-418. doi: 10.1111/hdi.12640. Epub 2018 Feb 13. No abstract available.

PMID:
29436151
48.

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.

Adkinson NF, Strauss WE, Macdougall IC, Bernard KE, Auerbach M, Kaper RF, Chertow GM, Krop JS.

Am J Hematol. 2018 May;93(5):683-690. doi: 10.1002/ajh.25060. Epub 2018 Feb 24.

49.

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.

Chin MP, Bakris GL, Block GA, Chertow GM, Goldsberry A, Inker LA, Heerspink HJL, O'Grady M, Pergola PE, Wanner C, Warnock DG, Meyer CJ.

Am J Nephrol. 2018;47(1):40-47. doi: 10.1159/000486398. Epub 2018 Jan 18.

50.

Benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease.

Cheung AK, Chertow GM, Greene T, Kimmel PL, Rahman M, Reboussin D, Rocco M; SPRINT Research Group.

J Intern Med. 2018 Jul;284(1):106-107. doi: 10.1111/joim.12735. Epub 2018 Mar 12. No abstract available.

PMID:
29385288

Supplemental Content

Loading ...
Support Center